| Literature DB >> 27716216 |
Glenn S Gerhard1,2, Qunyan Jin3, Barbara V Paynton3, Steven N Popoff3.
Abstract
BACKGROUND: The increasing use of next generation DNA sequencing in clinical medicine is exposing the need for more genetics education in physician training. We piloted an initiative to determine the feasibility of incorporating exome sequencing data generated from DNA obtained from cadavers used for teaching Anatomy into a first year medical student integrated block-style course.Entities:
Keywords: Cadaver; Exome sequencing; Medical education
Mesh:
Year: 2016 PMID: 27716216 PMCID: PMC5053090 DOI: 10.1186/s12920-016-0223-4
Source DB: PubMed Journal: BMC Med Genomics ISSN: 1755-8794 Impact factor: 3.063
Fig. 1Agarose gel electrophoresis of DNA isolated from cadaver tissues. MW = GeneRuler 1 kb Plus DNA Ladder (Thermo Fisher Scientific). Lane 1: Heart DNA extracted with DNeasy Blood & Tissue Kit. Lane 2: Liver DNA extracted with DNeasy Blood & Tissue Kit. Lane 3: Heart DNA extracted with FFPE kit. Lane 4: Liver DNA extracted with FFPE kit
DNA concentration and quality corresponding to lanes described in Fig. 1
| Tissue | DNA (ng/ul) | 260/280 nm |
|---|---|---|
| 1. Heart | 21.0 | 1.69 |
| 2. Liver | 39.0 | 1.84 |
| 3. Heart | 114.6 | 1.86 |
| 4. Liver | 61.9 | 1.87 |
DNA concentration and quality corresponding to lanes described in Fig. 2
| Tissue | DNA (ng/ul) | 260/280 nm |
|---|---|---|
| 1. Liver | 448.0 | 2.04 |
| 2. Heart | 246.9 | 1.90 |
| 3. Muscle | 88.0 | 1.90 |
| 4. Skin | 28.7 | 1.86 |
Fig. 2Agarose gel electrophoresis of DNA isolated from cadaver tissues using the DNeasy Blood & Tissue Kit. MW = Quick-load 1 kb DNA Ladder (New England BioLabs). Lane 1: Liver without RNAse treatment. Lane 2: Heart without RNAse treatment. Lane 3: Liver with RNAse treatment. Lane 4: Heart with RNAse treatment. Lane 5: Skeletal Muscle with RNAse treatment. Lane 6: Skin with RNAse treatment
Student priority and cause of death of cadavers sequenced
| Student priority | Cause of Death/Clinical Information |
|---|---|
| 2 | Breast Cancer and Pacemaker |
| 2 | Dementia |
| 1 | ALS |
| 1 | Gastric Cancer, Metastases |
| 1 | Prostate Cancer/Radical Prostatectomy/Metastases |
| 2 | Lung cancer |
| 1 | Myelodysplastic Syndrome |
Example set of SNVs selected from cadaver with diagnosis of Myelodysplastic syndrome
| Chr | dbSNP | Gene | 1000G MAF | ClinVar Significance | ClinVar Annotation |
|---|---|---|---|---|---|
| 5 | rs61748181 |
| 0.014 | Pathogenic | Aplastic_anemia |
| 17 | rs1042522 |
| 0.602 | Benign | Codon 72 polymorphism/neoplastic syndromes/hereditary |
| 22 | rs4680 |
| 0.389 | Benign | Catechol-o-methyltransferase polymorphism |
| 22 | rs1065852 |
| 0.255 | Pathogenic | Poor metabolism of Debrisoquine |
| 7 | rs10246939 |
| 0.549 | Pathogenic | Phenylthiocarbamide tasting |
| 5 | rs16891982 |
| 0.441 | - | Skin/hair/eye pigmentation variation |
| 11 | rs1126809 |
| 0.112 | Pathogenic | Waardenburg syndrome and ocular albinism |
| 16 | rs1805007 |
| 0.030 | Pathogenic | Red hair/fair skin/Increased analgesia from kappa-opioid receptor agonist |
| 12 | rs41276738 |
| 0.001 | Pathogenic | Von Willebrand disease |
| 1 | rs6025 |
| 0.994 | - | Thrombophilia due to factor V Leiden |
Please see Additional file 1 for chromosomal position, reference and alternative alleles, and depth of coverage